This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vivaglobin (Immune Globulin Subcutaneous Human) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (34)
Death (4)
Disability (1)
Reports by Reaction Type
Headache (7),
Off Label Use (4),
Infusion Site Swelling (4),
Transmission of AN Infectious Agent VIA A Medicinal Product (4),
Fatigue (3),
Thrombocytopenia (3),
Back Pain (3),
Dyspnoea (3),
Herpes Simplex Serology Positive (3),
Vertigo (3),
Vision Blurred (3),
Graft Versus Host Disease (2)
Below are a few examples of reports where side effects / adverse reactions may be related to Vivaglobin (Immune Globulin Subcutaneous Human). For a complete list or a specific selection of reports, please use the links above.
Possible Vivaglobin side effects in 20 year old female
Reported by a physician from United States on 2012-08-13
Patient: 20 year old female
Reactions: Haemorrhagic Cerebral Infarction, Superior Sagittal Sinus Thrombosis, Intracranial Venous Sinus Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Other drugs received by patient: Ethinyl Estradiol TAB; Drospirenone (Drospirenone)
Possible Vivaglobin side effects in 20 year old female
Reported by a physician from United States on 2012-08-03
Patient: 20 year old female
Reactions: Haemorrhagic Cerebral Infarction, Headache, Hemiparesis, Paraesthesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Other drugs received by patient: Ethinyl Estradiol TAB; Drospirenone (Drospirenone)
Possible Vivaglobin side effects in 67 year old male
Reported by a individual with unspecified qualification from Canada on 2012-07-18
Patient: 67 year old male
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-20
Patient: female, weighing 59.0 kg (129.7 pounds)
Reactions: Drug Ineffective, Asthenia, Infusion Site Swelling, Infusion Site Pruritus, Infusion Site Erythema
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in female
Reported by a physician from United States on 2012-06-19
Patient: female, weighing 61.2 kg (134.7 pounds)
Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product
Drug(s) suspected as cause:
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-06-07
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2011-03-29
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-11-22
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2011-01-06
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2011-01-26
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2009-11-17
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-08-03
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-07-06
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2011-02-22
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-01-18
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-05-11
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-08-31
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2009-11-17
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-03-16
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2009-12-15
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-02-16
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-09-28
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-10-26
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2010-12-21
Vivaglobin
Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
Indication: Humoral Immune Defect
Start date: 2011-04-27
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Other drugs received by patient: Vivaglobin
Possible Vivaglobin side effects in female
Reported by a pharmacist from United States on 2012-06-11
Patient: female, weighing 61.2 kg (134.7 pounds)
Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product
Drug(s) suspected as cause:
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-06-07
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-06-07
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-01-18
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-01-18
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-09-28
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-09-28
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2009-11-17
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2009-11-17
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-08-31
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-08-31
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2011-03-29
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2011-03-29
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2009-11-17
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2009-11-17
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2009-12-15
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2009-12-15
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-12-21
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-12-21
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-03-16
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-03-16
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2011-04-27
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2011-04-27
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-08-03
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-08-03
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-10-26
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-10-26
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2011-01-06
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2011-01-06
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2011-02-22
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2011-02-22
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-02-16
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-02-16
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-05-11
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-05-11
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-07-06
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-07-06
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2010-11-22
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2010-11-22
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Hypogammaglobulinaemia
Start date: 2011-01-26
Vivaglobin
Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
Indication: Immunodeficiency Common Variable
Start date: 2011-01-26
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Possible Vivaglobin side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-06-06
Patient: 70 year old female
Reactions: Dysphagia, Chills, Bone Pain, Pain, Headache, Eye Pain, Off Label Use, Syncope, Fatigue, Arthralgia, Diarrhoea Haemorrhagic, Vertigo, Disturbance in Attention, Vision Blurred, Ear Pain
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-01
Patient: 58 year old female
Reactions: Back Pain, Burning Sensation, Dyspnoea, Product Contamination Microbial, Hypersensitivity
Drug(s) suspected as cause:
Vivaglobin
Vivaglobin
Dosage: 30 ml, at rate of 1ml/minute
Indication: Immunodeficiency
Start date: 2011-05-25
Vivaglobin
Dosage: 30 ml, at rate of 1ml/minute
Indication: Hypogammaglobulinaemia
Start date: 2011-05-25
Vivaglobin
Dosage: 30 ml, at rate of 1ml/minute
Indication: Immunodeficiency
Start date: 2012-03-03
End date: 2012-03-03
Vivaglobin
Dosage: 30 ml, at rate of 1ml/minute
Indication: Hypogammaglobulinaemia
Start date: 2012-03-03
End date: 2012-03-03
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Other drugs received by patient: APO-Hydroxyquine (Hydroxychloroquine Sulfate); Calcium Carbonate; Vitamin D
Possible Vivaglobin side effects in 26 year old male
Reported by a individual with unspecified qualification from Belgium on 2012-05-07
Patient: 26 year old male
Reactions: Pulmonary Vasculitis, Cutaneous Vasculitis, Vasculitis Cerebral
Adverse event resulted in: death
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in female
Reported by a pharmacist from United States on 2012-04-23
Patient: female, weighing 61.2 kg (134.7 pounds)
Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product
Drug(s) suspected as cause:
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2009-11-17
End date: 2011-05-01
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2009-11-17
End date: 2011-05-01
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-10-26
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-10-26
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-02-16
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-02-16
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2011-01-06
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2011-01-06
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-03-16
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-03-16
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-05-11
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-05-11
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-08-31
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-08-31
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2011-04-27
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2011-04-27
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2009-12-15
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2009-12-15
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-06-07
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-06-07
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-11-22
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-11-22
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2011-03-29
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2011-03-29
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-01-18
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-01-18
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-07-06
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-07-06
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2011-01-26
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2011-01-26
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2011-02-22
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2011-02-22
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-09-28
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-09-28
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-12-21
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-12-21
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2009-11-17
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2009-11-17
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
Start date: 2010-08-03
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-08-03
Vivaglobin
Vivaglobin
Vivaglobin
Possible Vivaglobin side effects in 26 year old male
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-04-16
Patient: 26 year old male
Reactions: Cutaneous Vasculitis, Pulmonary Vasculitis, Vasculitis Cerebral
Adverse event resulted in: death
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in female
Reported by a pharmacist from United States on 2012-04-05
Patient: female
Reactions: Simplex Virus Test Positive, Transmission of AN Infectious Agent VIA A Medicinal Product
Drug(s) suspected as cause:
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Hypogammaglobulinaemia
End date: 2011-05-01
Vivaglobin
Dosage: (9.6 g 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
End date: 2011-05-01
Possible Vivaglobin side effects in 58 year old female
Reported by a individual with unspecified qualification from Canada on 2012-04-02
Patient: 58 year old female
Reactions: Burning Sensation, Back Pain, Product Contamination Microbial, Dyspnoea, Hypersensitivity, Injection Site Pain
Drug(s) suspected as cause:
Vivaglobin
Dosage: 30 ml, at rate of 1ml/minute, subcutaneous
Indication: Immunodeficiency
Start date: 2012-03-03
End date: 2012-03-03
Vivaglobin
Vivaglobin
Indication: Hypogammaglobulinaemia
Vivaglobin
Indication: Immunodeficiency
Vivaglobin
Indication: Immunodeficiency
Start date: 2011-05-25
Vivaglobin
Indication: Hypogammaglobulinaemia
Start date: 2011-05-25
Vivaglobin
Indication: Immunodeficiency
Vivaglobin
Indication: Hypogammaglobulinaemia
Vivaglobin
Indication: Immunodeficiency
Vivaglobin
Indication: Hypogammaglobulinaemia
Other drugs received by patient: APO-Hydroxyquine (Hydroxychloroquine Sulfate); Vitamin D; Calcium
Possible Vivaglobin side effects in 51 year old male
Reported by a physician from France on 2012-03-30
Patient: 51 year old male
Reactions: Diabetes Mellitus, Anaemia, Cytomegalovirus Infection, Toxicity To Various Agents, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
ACT HIB (Haemophilus B Conjugate Vaccine)
Indication: Immunisation
Start date: 2011-09-26
End date: 2011-09-26
ACT HIB (Haemophilus B Conjugate Vaccine)
Indication: Immunisation
Start date: 2011-11-08
End date: 2011-11-08
Ganciclovir
Dosage: 250 mg;qd;po
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-08-12
End date: 2011-08-26
Ganciclovir
Dosage: 250 mg;qd;po
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-07-15
End date: 2011-07-20
Noxafil
Dosage: 200 mg;tid
Indication: Oral Lichen Planus
Start date: 2011-07-15
End date: 2011-09-26
Prednisone
Dosage: 30 mg;bid
Indication: Acute Graft Versus Host Disease
Start date: 2011-07-15
End date: 2011-09-26
Vivaglobin
Dosage: 1 df;qw;iv
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-25
Other drugs received by patient: Foscavir
Possible Vivaglobin side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-27
Patient: 51 year old male
Reactions: Polydipsia, Incorrect Route of Drug Administration, Graft Versus Host Disease, Cytomegalovirus Test Positive, Diabetes Mellitus, Polyuria, Off Label Use, Bone Marrow Disorder, Haemoglobin Decreased, Thrombocytopenia, Leukopenia, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
ACT HIB (Haemophilus B Conjugate Vaccine)
Indication: Immunisation
Start date: 2011-09-26
End date: 2011-09-26
ACT HIB (Haemophilus B Conjugate Vaccine)
Indication: Immunisation
Start date: 2011-11-08
End date: 2011-11-08
Noxafil
Start date: 2011-07-15
End date: 2011-09-26
Vivaglobin
Dosage: 6.4 g 1x/week, 160mg/ml every 7 days intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-25
Other drugs received by patient: Foscavir; Prednisone TAB; Ganciclovir
Possible Vivaglobin side effects in 15 year old male
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-03-08
Patient: 15 year old male
Reactions: Pain, Sensory Loss, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Other drugs received by patient: Aerius (Desloratadine) Indication FOR USE WAS Allergy
Possible Vivaglobin side effects in 30 month old male
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-03-06
Patient: 30 month old male
Reactions: Abasia, Areflexia
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-05
Patient: 51 year old male
Reactions: Incorrect Route of Drug Administration, White Blood Cell Count Decreased, Polydipsia, Graft Versus Host Disease, Cytomegalovirus Test Positive, Polyuria, Haemoglobin Decreased, Bone Marrow Disorder, Off Label Use, Thrombocytopenia, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Other drugs received by patient: Ganciclovir; Voriconazole; Prednisone TAB; ACT HIB (Haemophilus B Conjugate Vaccine)
Possible Vivaglobin side effects in female
Reported by a physician from United States on 2012-03-05
Patient: female, weighing 59.9 kg (131.7 pounds)
Reactions: Weight Increased, Dysphonia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Other drugs received by patient: Levaquin; Zantac; Spiriva; Symbicort
Possible Vivaglobin side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-02-22
Patient: 59 year old female
Reactions: Staphylococcal Infection, Haematoma Infection, Infusion Site Swelling, Infusion Site Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Other drugs received by patient: Fluoxetine; Ramipril; Levothyroxine Sodium; Albuterol Sulfate; Furosemide (Furosemide); Omega-3 / 01168901 / (Omega-3 Triglycerides); Ezetimibe; Tylenol with Codeine (Panadeine CO); Atorvastatin; Gliclazide (Gliclazide); Lorazepam; Aspirin; Daily Multivitamin (Daily Multivitamin); Symbicort; Beres C-Vitamin (Ascorbic Acid); Calcium with Vitamin D (Calcium with Vitamin D); Ferrous Fumarate
Possible Vivaglobin side effects in 29 year old female
Reported by a physician from United States on 2012-02-07
Patient: 29 year old female, weighing 72.6 kg (159.7 pounds)
Reactions: Pancytopenia
Drug(s) suspected as cause:
Vivaglobin
Dosage: (11.2 g 1x/week, infused 70ml over 1-2 hours subcutaneous), ()
Indication: Immunodeficiency Common Variable
Start date: 2011-03-13
Vivaglobin
Dosage: (11.2 g 1x/week, infused 70ml over 1-2 hours subcutaneous), ()
Indication: Immunodeficiency Common Variable
Start date: 2010-07-07
Other drugs received by patient: Oracea; Aczone (Dapsone); Desonate (Desonide)
Possible Vivaglobin side effects in 76 year old female
Reported by a pharmacist from United States on 2012-02-07
Patient: 76 year old female, weighing 63.5 kg (139.7 pounds)
Reactions: Headache
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2009-01-01
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2009-12-01
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2011-02-04
Other drugs received by patient: Astelin (Diprophylline); Centrum Silver (Centrum Silver); Synthroid; Estradiol; Singulair; Xyzal; Clarinex; Reglan; Citracal D (Citracal + D); Metoclopramide; Advair Diskus 100 / 50
Possible Vivaglobin side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-02-07
Patient: 70 year old female
Reactions: Off Label Use, Fatigue, Arthralgia, Bone Pain, Vision Blurred, Vertigo, Ear Pain, Headache, Eye Pain
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in 47 year old female
Reported by a pharmacist from United States on 2012-02-07
Patient: 47 year old female, weighing 61.2 kg (134.7 pounds)
Reactions: Liver Function Test Abnormal, Hepatic Steatosis
Drug(s) suspected as cause:
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2010-01-01
End date: 2010-11-01
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Possible Vivaglobin side effects in 61 year old female
Reported by a pharmacist from United States on 2012-02-07
Patient: 61 year old female, weighing 104.3 kg (229.5 pounds)
Reactions: Thrombosis, Infusion Site Swelling, Infusion Site Erythema
Drug(s) suspected as cause:
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2009-05-01
Vivaglobin
Vivaglobin
Vivaglobin
Other drugs received by patient: Nexium; Ambien; Coumadin; Crestor; Ipratropium Bromide; Albuterol; Lexapro; Tricor; Xanax; Theocap (Theophylline); Coreg; Reglan; Singulair; Prednisone TAB; Advair Diskus 100 / 50
Possible Vivaglobin side effects in 57 year old female
Reported by a consumer/non-health professional from United States on 2012-02-07
Patient: 57 year old female
Reactions: Migraine, Urticaria, Musculoskeletal Stiffness, Meningitis Aseptic
Drug(s) suspected as cause:
Vivaglobin
Possible Vivaglobin side effects in female
Reported by a pharmacist from United States on 2012-02-07
Patient: female, weighing 46.7 kg (102.8 pounds)
Reactions: Convulsion
Drug(s) suspected as cause:
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Vivaglobin
Dosage: see image
Indication: Immune System Disorder
Start date: 2010-03-01
End date: 2011-02-01
Vivaglobin
Other drugs received by patient: Phenobarbital TAB; Urocit-K SR (Potassium Citrate); Keppra; Ovaza (Omega-3 Fatty Acids); Magnesium Oxide (Magnesium Oxide); Prilosec; Patanase 0.6% Nasal Spray (Olopatadine)
Possible Vivaglobin side effects in female
Reported by a physician from United States on 2012-02-07
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Back Pain, Nausea, Photophobia, Headache, Meningitis Aseptic, Infusion Site Urticaria, Infusion Site Swelling
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2007-02-01
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2007-02-01
Vivaglobin
Dosage: see image
Indication: Immunodeficiency Common Variable
Start date: 2007-02-01
Possible Vivaglobin side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-07
Patient: female, weighing 58.1 kg (127.7 pounds)
Reactions: Migraine, Dyspnoea, Insomnia, Dehydration, Decreased Appetite
Drug(s) suspected as cause:
Vivaglobin
Dosage: (40 ml 1x/week subcutaneous)
Indication: Immunodeficiency Common Variable
Start date: 2010-12-01
Vivaglobin
Possible Vivaglobin side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-01-27
Patient: 36 year old female
Reactions: Malaise, Palpitations, Vision Blurred
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
|
